Shoulder Innovations (SI) Assets Average (2025 - 2026)
Shoulder Innovations' (SI) quarterly Assets Average came in at $156.2 million in Q2 2026, down 5.42% quarter-over-quarter from $165.1 million in Q1 2026.
Powered by 
Analysis
Shoulder Innovations (SI) Assets Average (2025 - 2026) Analysis & Trends
Shoulder Innovations (SI) has reported Assets Average for 2 consecutive years, with $156.2 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Assets Average changed N/A year-over-year to $156.2 million; the trailing twelve-month figure through Jun 2026 stood at $156.2 million (changed N/A YoY), and the FY2025 full-year result was $106.5 million, changed N/A from the prior year.
- Assets Average fell to $156.2 million in Q2 2026 per SI's latest filing, from $165.1 million in the prior quarter.
- Across five years, Assets Average topped out at $173.8 million in Q4 2025 and bottomed at $127.8 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.79 Bn | 179.19 Bn | 7.27 Bn | 109.82 Bn |
| 2 | Intuitive Surgical | 124.16 Bn | 118.95 Bn | 1.96 Bn | 20.49 Bn |
| 3 | Medtronic | 118.51 Bn | 109.69 Bn | 6.34 Bn | 93.17 Bn |
| 4 | Stryker | 104.47 Bn | 100.99 Bn | 4.50 Bn | 47.11 Bn |
| 5 | Boston Scientific | 67.20 Bn | 66.66 Bn | 3.85 Bn | 44.78 Bn |
| 6 | Edwards Lifesciences | 49.85 Bn | 45.59 Bn | 1.35 Bn | 13.59 Bn |
| 7 | Alcon | 33.95 Bn | 32.49 Bn | 1.68 Bn | 31.36 Bn |
| 8 | Dexcom | 32.38 Bn | 30.44 Bn | 830.00 Mn | 6.54 Bn |
| 9 | Steris | 21.17 Bn | 20.69 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Shoulder Innovations | 413.68 Mn | 314.68 Mn | 13.44 Mn | 156.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 156.18 Mn |
| Mar 31, 2026 | 165.13 Mn |
| Dec 31, 2025 | 173.83 Mn |
| Sep 30, 2025 | 127.80 Mn |